Download PDF
Int J Angiol 2022; 31(04): 232-243
DOI: 10.1055/s-0042-1759527
Invited Article

Diagnosis and Management of Aortic Valvular Disease in the Elderly

Andrew J. Gorton 
1   Division of Cardiothoracic Surgery, Department of Surgery, University of Kentucky, Lexington, Kentucky
,
Suresh Keshavamurthy 
1   Division of Cardiothoracic Surgery, Department of Surgery, University of Kentucky, Lexington, Kentucky
,
Sibu P. Saha
1   Division of Cardiothoracic Surgery, Department of Surgery, University of Kentucky, Lexington, Kentucky
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Aortic valvular disease, including aortic stenosis and aortic regurgitation, is increasingly common with age. Due to the aging population, more elderly patients are presenting with aortic valve pathology and expectations for prompt diagnosis and efficacious treatment. The current paradigm for aortic valve disease is based on surgical or interventional therapy. In this review, we discuss the approach to diagnosing aortic valvular disease and the different options for treatment based on the most recent evidence.

Keywords

aortic valve disease - aortic dilation - cardiac biomarkers - cardiac surgery - cardiovascular surgical disease - diagnostic procedure - valvuloplasty


Publication History

Article published online:
29 November 2022

© 2022. International College of Angiology. This article is published by Thieme.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 “elderly, adj.”. OED Online. June 2022. Oxford University Press, Accessed on June 30, 2022 at: https://www.oed.com/
    PubMedGoogle Scholar
  • 2 Schettler G. Prävention der Herz- und Gefässkrankheiten. Lebensversicher Med 1984; 36 (08) 170-173
    PubMedGoogle Scholar
  • 3 Vespa J, Medina L, Armstrong D. Demographic Turning Points for the United States: Population Projections for 2020 to 2060 Current Population Reports, P25–1144. Washington, DC: US Census Bureau; . US Census Bur; Published online 2018: 1-13
    Google Scholar
  • 4 Fruitman DS, MacDougall CE, Ross DB. Cardiac surgery in octogenarians: can elderly patients benefit? Quality of life after cardiac surgery. Ann Thorac Surg 1999; 68 (06) 2129-2135
    CrossrefPubMedGoogle Scholar
  • 5 Zingone B, Gatti G, Rauber E. et al. Early and late outcomes of cardiac surgery in octogenarians. Ann Thorac Surg 2009; 87 (01) 71-78
    CrossrefPubMedGoogle Scholar
  • 6 Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet 2019; 394 (10206): 1365-1375
    CrossrefPubMedGoogle Scholar
  • 7 Sepehri A, Beggs T, Hassan A. et al. The impact of frailty on outcomes after cardiac surgery: a systematic review. J Thorac Cardiovasc Surg 2014; 148 (06) 3110-3117
    CrossrefPubMedGoogle Scholar
  • 8 Skaar E, Eide LSP, Norekvål TM. et al. A novel geriatric assessment frailty score predicts 2-year mortality after transcatheter aortic valve implantation. Eur Heart J Qual Care Clin Outcomes 2019; 5 (02) 153-160
    CrossrefPubMedGoogle Scholar
  • 9 Rockwood K, Song X, MacKnight C. et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005; 173 (05) 489-495
    CrossrefPubMedGoogle Scholar
  • 10 Lee JA, Yanagawa B, An KR, Arora RC, Verma S, Friedrich JO. Canadian Cardiovascular Surgery Meta-Analysis Working Group. Frailty and pre-frailty in cardiac surgery: a systematic review and meta-analysis of 66,448 patients. J Cardiothorac Surg 2021; 16 (01) 184
    CrossrefPubMedGoogle Scholar
  • 11 Yanagawa B, Graham MM, Afilalo J, Hassan A, Arora RC. Frailty as a risk predictor in cardiac surgery: Beyond the eyeball test. J Thorac Cardiovasc Surg 2019; 157 (05) 1905-1909
    CrossrefPubMedGoogle Scholar
  • 12 Tseng EE, Wisneski AD. Pathophysiology of the aortic valve. In: Baumgartner WA, Jacobs JP, Darling GE. eds. Adult and Pediatric Cardiac Surgery. STS Cardiothoracic Surgery E-Book. Chicago: Society of Thoracic Surgeons. 2020. ebook.sts.org . Accessed June 30, 2022
    Google Scholar
  • 13 Misfeld M, Sievers HH. Heart valve macro- and microstructure. Philos Trans R Soc Lond B Biol Sci 2007; 362 (1484): 1421-1436
    CrossrefPubMedGoogle Scholar
  • 14 Lindman BR, Bonow RO, Otto CM. Current management of calcific aortic stenosis. Circ Res 2013; 113 (02) 223-237
    CrossrefPubMedGoogle Scholar
  • 15 Owens DS, Katz R, Takasu J, Kronmal R, Budoff MJ, O'Brien KD. Incidence and progression of aortic valve calcium in the Multi-ethnic Study of Atherosclerosis (MESA). Am J Cardiol 2010; 105 (05) 701-708
    CrossrefPubMedGoogle Scholar
  • 16 Novaro GM, Katz R, Aviles RJ. et al. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study. J Am Coll Cardiol 2007; 50 (20) 1992-1998
    CrossrefPubMedGoogle Scholar
  • 17 Rosenhek R, Klaar U, Schemper M. et al. Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J 2004; 25 (03) 199-205
    CrossrefPubMedGoogle Scholar
  • 18 Otto CM, Burwash IG, Legget ME. et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997; 95 (09) 2262-2270
    CrossrefPubMedGoogle Scholar
  • 19 Miura S, Arita T, Kumamaru H. et al. Causes of death and mortality and evaluation of prognostic factors in patients with severe aortic stenosis in an aging society. J Cardiol 2015; 65 (05) 353-359
    CrossrefPubMedGoogle Scholar
  • 20 Essop MR, Nkomo VT. Rheumatic and nonrheumatic valvular heart disease: epidemiology, management, and prevention in Africa. Circulation 2005; 112 (23) 3584-3591
    CrossrefPubMedGoogle Scholar
  • 21 Sievers HH, Schmidtke C. A classification system for the bicuspid aortic valve from 304 surgical specimens. J Thorac Cardiovasc Surg 2007; 133 (05) 1226-1233
    CrossrefPubMedGoogle Scholar
  • 22 Mathieu P, Bossé Y, Huggins GS. et al. The pathology and pathobiology of bicuspid aortic valve: State of the art and novel research perspectives. J Pathol Clin Res 2015; 1 (04) 195-206
    CrossrefPubMedGoogle Scholar
  • 23 Jermihov PN, Jia L, Sacks MS, Gorman RC, Gorman III JH, Chandran KB. Effect of geometry on the leaflet stresses in simulated models of congenital bicuspid aortic valves. Cardiovasc Eng Technol 2011; 2 (01) 48-56
    CrossrefPubMedGoogle Scholar
  • 24 Tibazarwa KB, Volmink JA, Mayosi BM. Incidence of acute rheumatic fever in the world: a systematic review of population-based studies. Heart 2008; 94 (12) 1534-1540
    CrossrefPubMedGoogle Scholar
  • 25 Zühlke L, Engel ME, Lemmer CE. et al. The natural history of latent rheumatic heart disease in a 5 year follow-up study: a prospective observational study. BMC Cardiovasc Disord 2016; 16 (01) 46
    CrossrefPubMedGoogle Scholar
  • 26 Eveborn GW, Schirmer H, Heggelund G, Lunde P, Rasmussen K. The evolving epidemiology of valvular aortic stenosis. the Tromsø study. Heart 2013; 99 (06) 396-400
    CrossrefPubMedGoogle Scholar
  • 27 Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368 (9540): 1005-1011
    CrossrefPubMedGoogle Scholar
  • 28 Singh JP, Evans JC, Levy D. et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 1999; 83 (06) 897-902
    CrossrefPubMedGoogle Scholar
  • 29 Ross Jr J, Braunwald E. Aortic stenosis. Circulation 1968; 38 (suppl 1): 61-67
    PubMedGoogle Scholar
  • 30 Braunwald E. Aortic stenosis: then and now. Circulation 2018; 137 (20) 2099-2100
    CrossrefPubMedGoogle Scholar
  • 31 Pellikka PA, Sarano ME, Nishimura RA. et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005; 111 (24) 3290-3295
    CrossrefPubMedGoogle Scholar
  • 32 Rahko PS. Doppler and echocardiographic characteristics of patients having an Austin Flint murmur. Circulation 1991; 83 (06) 1940-1950
    CrossrefPubMedGoogle Scholar
  • 33 Chin CWL, Messika-Zeitoun D, Shah ASV. et al. A clinical risk score of myocardial fibrosis predicts adverse outcomes in aortic stenosis. Eur Heart J 2016; 37 (08) 713-723
    CrossrefPubMedGoogle Scholar
  • 34 Torres-Ramalho P, Araújo JP, Bettencourt P, Moura LM. Natriuretic peptides in aortic stenosis. Rev Port Cardiol 2012; 31 (10) 655-660
    CrossrefPubMedGoogle Scholar
  • 35 Chin CWL, Djohan AH, Lang CC. The role of cardiac biochemical markers in aortic stenosis. Biomarkers 2016; 21 (04) 316-327
    CrossrefPubMedGoogle Scholar
  • 36 Saeed S, Wasim D, Mohamed Ali A, Bleie Ø, Chambers JB. The electrocardiogram: Still a useful marker for LV fibrosis in aortic stenosis. J Electrocardiol 2021; 65 (65) 82-87
    CrossrefPubMedGoogle Scholar
  • 37 Maganti K, Rigolin VH, Sarano ME, Bonow RO. Valvular heart disease: diagnosis and management. Mayo Clin Proc 2010; 85 (05) 483-500
    CrossrefPubMedGoogle Scholar
  • 38 Clavel MA, Pibarot P, Messika-Zeitoun D. et al. Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. J Am Coll Cardiol 2014; 64 (12) 1202-1213
    CrossrefPubMedGoogle Scholar
  • 39 Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte Jr M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15 (04) 827-832
    CrossrefPubMedGoogle Scholar
  • 40 Francone M, Budde RPJ, Bremerich J. et al. Correction to: CT and MR imaging prior to transcatheter aortic valve implantation: standardisation of scanning protocols, measurements and reporting-a consensus document by the European Society of Cardiovascular Radiology (ESCR). Eur Radiol 2020; 30 (07) 4143-4144
    CrossrefPubMedGoogle Scholar
  • 41 Jassal DS, Shapiro MD, Neilan TG. et al. 64-slice multidetector computed tomography (MDCT) for detection of aortic regurgitation and quantification of severity. Invest Radiol 2007; 42 (07) 507-512
    CrossrefPubMedGoogle Scholar
  • 42 Baumgartner H, Hung J, Bermejo J. et al. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging 2017; 18 (03) 254-275
    CrossrefPubMedGoogle Scholar
  • 43 Otto CM, Nishimura RA, Bonow RO. et al. 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Vol 143. 2021. DOI: 10.1161/CIR.0000000000000923
    CrossrefGoogle Scholar
  • 44 Clavel MA, Magne J, Pibarot P. Low-gradient aortic stenosis. Eur Heart J 2016; 37 (34) 2645-2657
    CrossrefPubMedGoogle Scholar
  • 45 Faber M, Sonne C, Rosner S. et al. Predicting the need of aortic valve surgery in patients with chronic aortic regurgitation: a comparison between cardiovascular magnetic resonance imaging and transthoracic echocardiography. Int J Cardiovasc Imaging 2021; 37 (10) 2993-3001
    CrossrefPubMedGoogle Scholar
  • 46 Woldendorp K, Bannon PG, Grieve SM. Evaluation of aortic stenosis using cardiovascular magnetic resonance: a systematic review & meta-analysis. J Cardiovasc Magn Reson 2020; 22 (01) 45
    CrossrefPubMedGoogle Scholar
  • 47 Bekeredjian R, Grayburn PA. Valvular heart disease: aortic regurgitation. Circulation 2005; 112 (01) 125-134
    CrossrefPubMedGoogle Scholar
  • 48 Farmer JA. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis (the SEAS trial). Curr Atheroscler Rep 2009; 11 (02) 82-83
    PubMedGoogle Scholar
  • 49 Cowell SJ, Newby DE, Prescott RJ. et al; Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005; 352 (23) 2389-2397
    CrossrefPubMedGoogle Scholar
  • 50 Helske S, Otto CM. Lipid lowering in aortic stenosis: still some light at the end of the tunnel?. Circulation 2009; 119 (20) 2653-2655
    CrossrefPubMedGoogle Scholar
  • 51 Moura LM, Ramos SF, Zamorano JL. et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol 2007; 49 (05) 554-561
    CrossrefPubMedGoogle Scholar
  • 52 Hachicha Z, Dumesnil JG, Pibarot P. Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis. J Am Coll Cardiol 2009; 54 (11) 1003-1011
    CrossrefPubMedGoogle Scholar
  • 53 Briand M, Dumesnil JG, Kadem L. et al. Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment. J Am Coll Cardiol 2005; 46 (02) 291-298
    CrossrefPubMedGoogle Scholar
  • 54 O'Brien KD, Probstfield JL, Caulfield MT. et al. Angiotensin-converting enzyme inhibitors and change in aortic valve calcium. Arch Intern Med 2005; 165 (08) 858-862
    CrossrefPubMedGoogle Scholar
  • 55 Alsidawi S, Couto M, López-Candales A. Acquired Von Willebrand syndrome in aortic stenosis: case report and review. Bol Asoc Med P R 2015; 107 (02) 86-88
    PubMedGoogle Scholar
  • 56 King RM, Pluth JR, Giuliani ER. The association of unexplained gastrointestinal bleeding with calcific aortic stenosis. Ann Thorac Surg 1987; 44 (05) 514-516
    CrossrefPubMedGoogle Scholar
  • 57 Ishii K, Hirota Y, Suwa M, Kita Y, Onaka H, Kawamura K. Natural history and left ventricular response in chronic aortic regurgitation. Am J Cardiol 1996; 78 (03) 357-361
    CrossrefPubMedGoogle Scholar
  • 58 Lin M, Chiang HT, Lin SL. et al. Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy. J Am Coll Cardiol 1994; 24 (04) 1046-1053
    CrossrefPubMedGoogle Scholar
  • 59 Shah RM, Singh M, Bhuriya R, Molnar J, Arora RR, Khosla S. Favorable effects of vasodilators on left ventricular remodeling in asymptomatic patients with chronic moderate-severe aortic regurgitation and normal ejection fraction: a meta-analysis of clinical trials. Clin Cardiol 2012; 35 (10) 619-62
    CrossrefPubMedGoogle Scholar
  • 60 Thourani VH, Myung R, Kilgo P. et al. Long-term outcomes after isolated aortic valve replacement in octogenarians: a modern perspective. Ann Thorac Surg 2008; 86 (05) 1458-1464 , discussion 1464–1465
    CrossrefPubMedGoogle Scholar
  • 61 Mølstad P, Veel T, Rynning S. Long-term survival after aortic valve replacement in octogenarians and high-risk subgroups. Eur J Cardiothorac Surg 2012; 42 (06) 934-940
    CrossrefPubMedGoogle Scholar
  • 62 Bacchetta MD, Ko W, Girardi LN. et al. Outcomes of cardiac surgery in nonagenarians: a 10-year experience. Ann Thorac Surg 2003; 75 (04) 1215-1220
    CrossrefPubMedGoogle Scholar
  • 63 Elsisy MF, Schaff HV, Crestanello JA, Alkhouli MA, Stulak JM, Stephens EH. Outcomes of cardiac surgery in nonagenarians. J Card Surg 2022; 37 (06) 1664-1670
    CrossrefPubMedGoogle Scholar
  • 64 Kvidal P, Bergström R, Hörte LG, Ståhle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 2000; 35 (03) 747-756
    CrossrefPubMedGoogle Scholar
  • 65 Stewart BF, Siscovick D, Lind BK. et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997; 29 (03) 630-634
    CrossrefPubMedGoogle Scholar
  • 66 Pibarot P, Dumesnil JG. Improving assessment of aortic stenosis. J Am Coll Cardiol 2012; 60 (03) 169-180
    CrossrefPubMedGoogle Scholar
  • 67 Paradis JM, Fried J, Nazif T. et al. Aortic stenosis and coronary artery disease: what do we know? What don't we know? A comprehensive review of the literature with proposed treatment algorithms. Eur Heart J 2014; 35 (31) 2069-2082
    CrossrefPubMedGoogle Scholar
  • 68 Hannan EL, Wu C, Bennett EV. et al. Risk index for predicting in-hospital mortality for cardiac valve surgery. Ann Thorac Surg 2007; 83 (03) 921-929
    CrossrefPubMedGoogle Scholar
  • 69 Cappabianca G, Ferrarese S, Musazzi A. et al. Predictive factors of long-term survival in the octogenarian undergoing surgical aortic valve replacement: 12-year single-centre follow-up. Heart Vessels 2016; 31 (11) 1798-1805
    CrossrefPubMedGoogle Scholar
  • 70 Kuo K, Shah P, Hiebert B. et al. Predictors of survival, functional survival, and hospital readmission in octogenarians after surgical aortic valve replacement. J Thorac Cardiovasc Surg 2017; 154 (05) 1544-1553.e1
    CrossrefPubMedGoogle Scholar
  • 71 ElBardissi AW, Shekar P, Couper GS, Cohn LH. Minimally invasive aortic valve replacement in octogenarian, high-risk, transcatheter aortic valve implantation candidates. J Thorac Cardiovasc Surg 2011; 141 (02) 328-335
    CrossrefPubMedGoogle Scholar
  • 72 Chiariello GA, Bruno P, Villa E. et al. Aortic valve replacement in elderly patients with small aortic annulus: results with three different bioprostheses. Innovations (Phila) 2019; 14 (01) 27-36
    CrossrefPubMedGoogle Scholar
  • 73 Wong CHM, Chan JSK, Sanli D, Rahimli R, Harky A. Aortic valve repair or replacement in patients with aortic regurgitation: a systematic review and meta-analysis. J Card Surg 2019; 34 (06) 377-384
    CrossrefPubMedGoogle Scholar
  • 74 Zeeshan A, Idrees JJ, Johnston DR. et al. Durability of aortic valve cusp repair with and without annular support. Ann Thorac Surg 2018; 105 (03) 739-748
    CrossrefPubMedGoogle Scholar
  • 75 Urbanski PP, Jankulovski A, Doldurov K. et al. Reconstructive aortic valve surgery in the elderly: techniques and outcomes. J Thorac Cardiovasc Surg 2018; 155 (04) 1414-1420
    CrossrefPubMedGoogle Scholar
  • 76 Carroll JD, Mack MJ, Vemulapalli S. et al. STS-ACC TVT registry of transcatheter aortic valve replacement. Ann Thorac Surg 2021; 111 (02) 701-722
    CrossrefPubMedGoogle Scholar
  • 77 Leon MB, Smith CR, Mack M. et al; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363 (17) 1597-1607
    CrossrefPubMedGoogle Scholar
  • 78 Smith CR, Leon MB, Mack MJ. et al; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364 (23) 2187-2198
    CrossrefPubMedGoogle Scholar
  • 79 Leon MB, Smith CR, Mack MJ. et al; PARTNER 2 Investigators. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016; 374 (17) 1609-1620
    CrossrefPubMedGoogle Scholar
  • 80 Mack MJ, Leon MB, Thourani VH. et al; PARTNER 3 Investigators. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019; 380 (18) 1695-1705
    CrossrefPubMedGoogle Scholar
  • 81 Gleason TG, Reardon MJ, Popma JJ. et al; CoreValve U.S. Pivotal High Risk Trial Clinical Investigators. 5-year outcomes of self-expanding transcatheter versus surgical aortic valve replacement in high-risk patients. J Am Coll Cardiol 2018; 72 (22) 2687-2696
    CrossrefPubMedGoogle Scholar
  • 82 Reardon MJ, Van Mieghem NM, Popma JJ. et al; SURTAVI Investigators. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 2017; 376 (14) 1321-1331
    CrossrefPubMedGoogle Scholar
  • 83 Svensson LG, Adams DH, Bonow RO. et al. Aortic valve and ascending aorta guidelines for management and quality measures. Ann Thorac Surg 2013; 95 (suppl 6): S1-S66
    CrossrefPubMedGoogle Scholar
  • 84 Tarus A, Tinica G, Bacusca A, Artene B, Popa IV, Burlacu A. Coronary revascularization during treatment of severe aortic stenosis: a meta-analysis of the complete percutaneous approach (PCI plus TAVR) versus the complete surgical approach (CABG plus SAVR). J Card Surg 2020; 35 (08) 2009-2016
    CrossrefPubMedGoogle Scholar